Brentuximab Vedotin for Steroid Refractory GvHD

Clinical trial NCT01596218 · COMPLETED

Trial details

NCT number: NCT01596218
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Graft vs. Host Disease

Start date: 2012-07-01
Primary completion: 2016-06-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.